Navigation Links
Scientists slow brain tumor growth in mice
Date:5/13/2014

itical to keeping messenger RNA long in healthy cells and that its reduction promotes tumor growth. The key research finding in this study was that restoring CFIm25 levels in brain tumors dramatically reduced their growth.

"Understanding how messenger RNA length is regulated will allow researchers to begin to develop new strategies aimed at interfering with the process that causes unusual messenger RNA shortening during the formation of tumors," Wagner said.

Additional preclinical tests are needed before the strategy can be evaluated in humans.

"The work described in the Nature paper by Drs. Wagner and Shyu stems from a high-risk/high-impact Cancer Prevention & Research Institute of Texas (CPRIT) proposal they submitted together and received several years ago," said Rod Kellems, Ph.D., professor and chairman of the Department of Biochemistry and Molecular Biology at the UTHealth Medical School.

"Their research is of fundamental biological importance in that it seeks to understand the role of messenger RNA length regulation in gene expression," Kellems said. "Using a sophisticated combination of biochemistry, genetics and bioinformatics, their research uncovered an important role for a specific protein that is linked to glioblastoma tumor suppression."

Other UTHealth contributors include postdoctoral fellow Chioniso P. Masamha, Ph.D.; research associate Todd R. Albrecht; and neurosurgery associate professor Min Li, Ph.D., along with a postdoctoral fellow in his lab, Jingxuan Yang, Ph.D.

"Grade IV astrocytomas (GBM) are the most frequent and malignant form of brain tumor, with a median survival time of only 14.6 months. The mechanisms underlying gliomagenesis remain largely unknown, and limited choices are available for patients with GBM," said Min Li, director of the Cancer Research Program in the Vivian L. Smith Department of Neurosurgery at UTHealth and a member of the Mischer Neuroscience Institute at
'/>"/>

Contact: Robert Cahill
Robert.Cahill@uth.tmc.edu
713-500-3030
University of Texas Health Science Center at Houston
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. UBC scientists find new way to mobilize immune system against viruses
2. Dartmouth scientists identify genetic blueprint for cancerous tumors of the appendix
3. Scientists decode epigenetic mechanisms distinguishing stem cell function and blood cancer
4. Scientists identify new protein in the neurological disorder dystonia
5. Scientists awarded grant to develop diagnostics for cancer, rheumatoid arthritis, colitis
6. Norwegian neuroscientists elected to National Academy of Sciences
7. NIH scientists establish monkey model of hantavirus disease
8. Stanford scientists create circuit board modeled on the human brain
9. A civil war inside our cells: Scientists show how our bodies fight off jumping genes
10. Scientists find way to target cells resistant to chemo
11. Scientists identify cancer specific cell for potential treatment of gastric cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scientists slow brain tumor growth in mice
(Date:11/26/2014)... November 26, 2014 Loffler Companies has ... Week in Imaging, an online information and news publication ... is the sixth consecutive year Loffler has earned this ... , The Elite Dealer Awards honor the best and ... year’s Elite Dealer honorees were chosen for their innovative ...
(Date:11/26/2014)... Rosa, California (PRWEB) November 26, 2014 ... making never before seen reductions in prices of their ... and Liposomal Vitamin D3 . Discounts of ... , GI for Life’s proprietary ColoVite supplement ... board-certified gastroenterologists to promote colon health. One easy-to-take colon ...
(Date:11/26/2014)... ISI Telemanagement Solutions, Inc., a ... award the 2014 Lync Pioneer Award ... as a great honor to ISI, who continues ... Specifically, ISI offers an integrated collaboration reporting and ... including voice, video, Lync IM, and conferencing. ...
(Date:11/26/2014)... Medical suction and vacuum products have ... This score represents steady growth in the price of ... as a result of swelling demand for healthcare services ... largely considered nondiscretionary. IBISWorld market research analyst, Anna Son, ... degree of flexibility, given the low level of price ...
(Date:11/26/2014)... Louisiana Back Institute, leaders of ... minimally invasive spine surgery, announces today the addition ... growing provider network of orthopedic spine surgeons and ... the network’s continuing success providing the most innovative ... who are suffering from orthopedic spine conditions and ...
Breaking Medicine News(10 mins):Health News:Loffler Companies Recognized as an Elite Dealer for Sixth Consecutive Year 2Health News:GI For Life Slashes Prices by 40% on Liposomal Vitamin D3 and ColoVite Colon Health Formula for a Limited Time 2Health News:ISI Telemanagement Solutions, Inc. has been Awarded the 2014 Microsoft Lync Pioneer Award 2Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 4Health News:Louisiana Back Institute Welcomes Dr. K. Samer Shamieh into Medical Provider Network 2
... &,Gamble Company (NYSE: PG ) announced net sales ... Sales were up behind strong volume growth,from continued success ... regions. Organic volume increased six percent and,organic sales were ... increased 17 percent to $0.98 per share, above the ...
... Doctors can qualify for up to $100,000 in bonuses, ... the nation,s largest effort to reward physicians for,delivery of ... home,approach to providing health care by launching the BTE ... they have,adopted really good systems and processes of care, ...
... Approve 3f(R) Aortic Bioprosthesis for Sale ... in Canada ... Company Updates Financial Outlook for 2008, MINNEAPOLIS, Jan. 31 ATS Medical, ... today announced it has received a request,for additional information and clarification from the ...
... Jan. 31 Easter Seals, with funding from ... launching a new,nationwide program to help returning veterans ... Fitness Program -- an in-home,computer-based cognitive training program ... other essential Easter Seals services and supports., ...
... is widespread and strong throughout Minnesota, MINNEAPOLIS, ... by,ClearWay Minnesota(SM) found that 76 percent of Minnesotans ... strong support. The,survey also provides evidence of strong ... ideological affiliation,income, age and gender. The survey was ...
... an inflammatory autoimmune disease, tend to die younger ... explanation for this increasingly recognized fact is that ... elevation of the C-reactive protein (CRP) level has ... population. However, other highly inflammatory diseasesCrohns, for ...
Cached Medicine News:Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 2Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 3Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 4Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 5Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 6Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 7Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 8Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 9Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 10Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 11Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 12Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 13Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 14Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 15Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 16Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 17Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 18Health News:P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company 19Health News:Bridges to Excellence Launches Medical Home Program 2Health News:Bridges to Excellence Launches Medical Home Program 3Health News:Bridges to Excellence Launches Medical Home Program 4Health News:ATS Medical Provides Update on First Generation Tissue Valve Approval 2Health News:ATS Medical Provides Update on First Generation Tissue Valve Approval 3Health News:Easter Seals Launches Nationwide Program for U.S. Service Members and Veterans Deployed to Iraq or Afghanistan with Traumatic Brain Injury 2Health News:Easter Seals Launches Nationwide Program for U.S. Service Members and Veterans Deployed to Iraq or Afghanistan with Traumatic Brain Injury 3Health News:Easter Seals Launches Nationwide Program for U.S. Service Members and Veterans Deployed to Iraq or Afghanistan with Traumatic Brain Injury 4Health News:New Survey Finds 76 Percent of Minnesotans Support Smoke-Free Law 2Health News:The HLA-DRB1 gene and premature death in rheumatoid arthritis 2Health News:The HLA-DRB1 gene and premature death in rheumatoid arthritis 3
(Date:11/26/2014)... , Nov. 25, 2014 Amgen (NASDAQ: ... today announced that AMAGINE-2 TM , a pivotal, multi-arm Phase ... 1,800 patients with moderate-to-severe plaque psoriasis, met its primary endpoints ... at week 12. Brodalumab 210 mg given every two weeks ... be superior to Stelara on the primary endpoint of achieving ...
(Date:11/26/2014)... , Nov. 26, 2014 / -- China Nepstar Chain Drugstore Ltd. (NYSE: ... leading retail drugstore chain in China ... today announced the appointment of Ms. Rebecca Yingnan ... immediately. Ms.Zhang has over 20 years ... in March 1999. Prior to Ms. Zhang,s appointment as ...
(Date:11/24/2014)... Juno Therapeutics today announced that the ... company,s JCAR015 chimeric antigen receptor product candidate.  The ... refractory B-cell acute lymphoblastic leukemia and was filed ... Center, where Phase 1 clinical trials are currently ... important news for patients who may benefit from ...
Breaking Medicine Technology:Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 3Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 5Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 6Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 7Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 8Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 9Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 10China Nepstar Chain Drugstore Appoints Ms. Rebecca Yingnan Zhang as Chief Operating Officer 2China Nepstar Chain Drugstore Appoints Ms. Rebecca Yingnan Zhang as Chief Operating Officer 3Juno T Cell Therapy For Leukemia Granted FDA Breakthrough Therapy Designation 2Juno T Cell Therapy For Leukemia Granted FDA Breakthrough Therapy Designation 3
Automated QC module...
... The FLEXLINK software links ... at the bedside, making data ... eliminating the risk of incorrect ... is part of 1st automatic, ...
... is a unique tool that ... commands to activate shortcut keys ... the need to perform manual ... can devote your full attention ...
... Manometry Application for POLYGRAM NET™ (PNET) ... recorder to record and analyze pressure, ... esophageal manometry procedures. The PNET software ... solid-state or water-perfused manometry catheters and ...
Medicine Products: